GLP-1 and Cardiovascular Risk Reduction Mechanisms
Multiple pathways in heart and blood vessels explain how GLP-1 drugs cut cardiovascular risk.
Rafael Ibrahim
Editor at Large
Rafael Ibrahim is a editor at large at glpletter covering emerging glp-1 indications. Based in Lisbon, Rafael has written for glpletter since 2018.
1 story · Lisbon
Multiple pathways in heart and blood vessels explain how GLP-1 drugs cut cardiovascular risk.